

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of heat generation (GO:0031652) | 7.31779078 |
| 2 | regulation of fever generation (GO:0031620) | 7.31686809 |
| 3 | positive regulation of chemokine biosynthetic process (GO:0045080) | 6.01722501 |
| 4 | cellular response to exogenous dsRNA (GO:0071360) | 5.97388262 |
| 5 | regulation of chronic inflammatory response (GO:0002676) | 5.88087778 |
| 6 | regulation of heat generation (GO:0031650) | 5.64097827 |
| 7 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 5.55085656 |
| 8 | regulation of T cell cytokine production (GO:0002724) | 5.52266913 |
| 9 | regulation of cytokine secretion involved in immune response (GO:0002739) | 5.41505471 |
| 10 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 5.19638760 |
| 11 | regulation of chemokine biosynthetic process (GO:0045073) | 5.14444539 |
| 12 | regulation of podosome assembly (GO:0071801) | 5.07275489 |
| 13 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 5.02239247 |
| 14 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.88023179 |
| 15 | positive regulation of type 2 immune response (GO:0002830) | 4.78814443 |
| 16 | respiratory burst (GO:0045730) | 4.77639994 |
| 17 | positive regulation of T cell cytokine production (GO:0002726) | 4.77382596 |
| 18 | positive regulation by symbiont of host defense response (GO:0052509) | 4.76879641 |
| 19 | modulation by symbiont of host defense response (GO:0052031) | 4.76879641 |
| 20 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.76879641 |
| 21 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.76879641 |
| 22 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.76879641 |
| 23 | modulation by symbiont of host immune response (GO:0052553) | 4.76879641 |
| 24 | leukocyte aggregation (GO:0070486) | 4.76596817 |
| 25 | cellular response to interferon-beta (GO:0035458) | 4.74636533 |
| 26 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.61332574 |
| 27 | cellular response to ATP (GO:0071318) | 4.51309494 |
| 28 | negative regulation of interleukin-12 production (GO:0032695) | 4.42703813 |
| 29 | negative regulation of viral genome replication (GO:0045071) | 4.41552319 |
| 30 | microglial cell activation (GO:0001774) | 4.34748596 |
| 31 | regulation of vitamin metabolic process (GO:0030656) | 4.33344488 |
| 32 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 4.29099179 |
| 33 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 4.27064114 |
| 34 | regulation of mononuclear cell migration (GO:0071675) | 4.24558519 |
| 35 | type I interferon signaling pathway (GO:0060337) | 4.23624150 |
| 36 | cellular response to type I interferon (GO:0071357) | 4.23624150 |
| 37 | response to type I interferon (GO:0034340) | 4.18751540 |
| 38 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 4.17657635 |
| 39 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 4.17657635 |
| 40 | lymphocyte chemotaxis (GO:0048247) | 4.07779108 |
| 41 | response to interferon-beta (GO:0035456) | 4.06967889 |
| 42 | regulation of histone phosphorylation (GO:0033127) | 4.03052609 |
| 43 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.02249574 |
| 44 | positive regulation of interferon-alpha production (GO:0032727) | 4.01734211 |
| 45 | response to peptidoglycan (GO:0032494) | 3.87213788 |
| 46 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.86355706 |
| 47 | granulocyte activation (GO:0036230) | 3.85183038 |
| 48 | regulation of immunoglobulin secretion (GO:0051023) | 3.83845377 |
| 49 | regulation of interferon-alpha production (GO:0032647) | 3.83714573 |
| 50 | macrophage activation involved in immune response (GO:0002281) | 3.83449401 |
| 51 | regulation of type 2 immune response (GO:0002828) | 3.82597834 |
| 52 | positive regulation of defense response to virus by host (GO:0002230) | 3.80973098 |
| 53 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.79749209 |
| 54 | response to protozoan (GO:0001562) | 3.75474678 |
| 55 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.70136106 |
| 56 | positive regulation of lymphocyte migration (GO:2000403) | 3.67580590 |
| 57 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.66845479 |
| 58 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.65340962 |
| 59 | cellular response to nicotine (GO:0071316) | 3.63286078 |
| 60 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.63091596 |
| 61 | response to manganese ion (GO:0010042) | 3.62883889 |
| 62 | negative regulation of T cell mediated immunity (GO:0002710) | 3.62699603 |
| 63 | sensory perception of smell (GO:0007608) | 3.61630805 |
| 64 | regulation of T-helper cell differentiation (GO:0045622) | 3.60652191 |
| 65 | macrophage activation (GO:0042116) | 3.58400365 |
| 66 | NIK/NF-kappaB signaling (GO:0038061) | 3.57405311 |
| 67 | monocyte chemotaxis (GO:0002548) | 3.57371993 |
| 68 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.56421730 |
| 69 | positive regulation vascular endothelial growth factor production (GO:0010575) | 3.55771740 |
| 70 | T-helper 1 type immune response (GO:0042088) | 3.55566854 |
| 71 | indole-containing compound catabolic process (GO:0042436) | 3.54289764 |
| 72 | indolalkylamine catabolic process (GO:0046218) | 3.54289764 |
| 73 | tryptophan catabolic process (GO:0006569) | 3.54289764 |
| 74 | neutrophil activation involved in immune response (GO:0002283) | 3.53934599 |
| 75 | positive regulation of acute inflammatory response (GO:0002675) | 3.51665675 |
| 76 | reactive oxygen species biosynthetic process (GO:1903409) | 3.50099547 |
| 77 | I-kappaB phosphorylation (GO:0007252) | 3.48908748 |
| 78 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.46085760 |
| 79 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.45459776 |
| 80 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.41666890 |
| 81 | response to host immune response (GO:0052572) | 3.41666890 |
| 82 | regulation of vascular endothelial growth factor production (GO:0010574) | 3.39222713 |
| 83 | leukocyte degranulation (GO:0043299) | 3.37539719 |
| 84 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.35467324 |
| 85 | superoxide anion generation (GO:0042554) | 3.35389222 |
| 86 | negative regulation of amino acid transport (GO:0051956) | 3.33954434 |
| 87 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.33371697 |
| 88 | positive regulation of mast cell degranulation (GO:0043306) | 3.33371697 |
| 89 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.31740592 |
| 90 | regulation of NF-kappaB import into nucleus (GO:0042345) | 3.29136645 |
| 91 | negative regulation by host of viral transcription (GO:0043922) | 3.28946567 |
| 92 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.28532645 |
| 93 | cellular response to interferon-alpha (GO:0035457) | 3.27779139 |
| 94 | kynurenine metabolic process (GO:0070189) | 3.27300682 |
| 95 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.26593131 |
| 96 | positive regulation of prostaglandin secretion (GO:0032308) | 3.26376705 |
| 97 | regulation of T cell mediated immunity (GO:0002709) | 3.24178244 |
| 98 | myeloid cell activation involved in immune response (GO:0002275) | 3.21756274 |
| 99 | natural killer cell activation involved in immune response (GO:0002323) | 3.19576771 |
| 100 | negative regulation of lipid storage (GO:0010888) | 3.19199004 |
| 101 | cellular response to virus (GO:0098586) | 3.18867918 |
| 102 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.18737889 |
| 103 | response to interferon-alpha (GO:0035455) | 3.15692286 |
| 104 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.13555648 |
| 105 | regulation of growth of symbiont in host (GO:0044126) | 3.13555648 |
| 106 | negative regulation of growth of symbiont in host (GO:0044130) | 3.13555648 |
| 107 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.13555648 |
| 108 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.13291063 |
| 109 | defense response to protozoan (GO:0042832) | 3.13181112 |
| 110 | cellular response to molecule of bacterial origin (GO:0071219) | 3.12914330 |
| 111 | negative regulation of type 2 immune response (GO:0002829) | 3.10304068 |
| 112 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.09872477 |
| 113 | positive regulation of chemokine production (GO:0032722) | 3.09139591 |
| 114 | regulation of prostaglandin secretion (GO:0032306) | 3.08452913 |
| 115 | regulation of interleukin-12 production (GO:0032655) | 3.08111050 |
| 116 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.07169906 |
| 117 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.06965655 |
| 118 | germinal center formation (GO:0002467) | 3.06305526 |
| 119 | myeloid dendritic cell differentiation (GO:0043011) | 3.05979686 |
| 120 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.05391535 |
| 121 | response to vitamin D (GO:0033280) | 3.05363710 |
| 122 | positive regulation of natural killer cell activation (GO:0032816) | 3.02631927 |
| 123 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.02389795 |
| 124 | response to host (GO:0075136) | 3.02389795 |
| 125 | response to host defenses (GO:0052200) | 3.02389795 |
| 126 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.02204850 |
| 127 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 3.01512807 |
| 128 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.01445621 |
| 129 | positive regulation of T cell mediated immunity (GO:0002711) | 3.00523691 |
| 130 | immunoglobulin mediated immune response (GO:0016064) | 3.00483953 |
| 131 | neutrophil chemotaxis (GO:0030593) | 3.00209434 |
| 132 | positive regulation of leukocyte degranulation (GO:0043302) | 2.99902514 |
| 133 | cellular response to ethanol (GO:0071361) | 2.99476612 |
| 134 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.99171180 |
| 135 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.97141522 |
| 136 | inflammatory response to antigenic stimulus (GO:0002437) | 2.97023787 |
| 137 | ventricular system development (GO:0021591) | 2.96793623 |
| 138 | positive regulation of interferon-beta production (GO:0032728) | 2.96545595 |
| 139 | negative regulation of viral process (GO:0048525) | 2.96146588 |
| 140 | positive regulation of interleukin-6 production (GO:0032755) | 2.95223753 |
| 141 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.94445125 |
| 142 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.93804823 |
| 143 | regulation of lymphocyte migration (GO:2000401) | 2.91722855 |
| 144 | amine catabolic process (GO:0009310) | 2.91392381 |
| 145 | cellular biogenic amine catabolic process (GO:0042402) | 2.91392381 |
| 146 | neutrophil migration (GO:1990266) | 2.91216539 |
| 147 | regulation of defense response to virus by host (GO:0050691) | 2.90820922 |
| 148 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.89316361 |
| 149 | cellular response to lipopolysaccharide (GO:0071222) | 2.87892291 |
| 150 | regulation of natural killer cell activation (GO:0032814) | 2.86762218 |
| 151 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.86688966 |
| 152 | activation of MAPKKK activity (GO:0000185) | 2.86348106 |
| 153 | eosinophil chemotaxis (GO:0048245) | 2.85299252 |
| 154 | positive regulation of interleukin-12 production (GO:0032735) | 2.85093595 |
| 155 | negative regulation of cytokine secretion (GO:0050710) | 2.81990234 |
| 156 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.81714928 |
| 157 | response to ATP (GO:0033198) | 2.80828085 |
| 158 | regulation of T cell tolerance induction (GO:0002664) | 2.80826944 |
| 159 | tryptophan metabolic process (GO:0006568) | 2.80116818 |
| 160 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.79614281 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.38376687 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.00946151 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.82924312 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.32474414 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.82636569 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 3.77388638 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.56962010 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.07160684 |
| 9 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.78001125 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.70142872 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.36006971 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30613408 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.23924959 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.21521168 |
| 15 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.12779349 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.09505162 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.02753044 |
| 18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.90462114 |
| 19 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.78116443 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.63310119 |
| 21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.61121323 |
| 22 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.59626034 |
| 23 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.55711088 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.55532871 |
| 25 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.55078701 |
| 26 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.54468524 |
| 27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.52839540 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.45516613 |
| 29 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42423623 |
| 30 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.38817979 |
| 31 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.38302721 |
| 32 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38112851 |
| 33 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.34851470 |
| 34 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.34832076 |
| 35 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.34627296 |
| 36 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.33212100 |
| 37 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.32409480 |
| 38 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31346516 |
| 39 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.26830250 |
| 40 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23913076 |
| 41 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.23397629 |
| 42 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23397629 |
| 43 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23317813 |
| 44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.20029282 |
| 45 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.19692493 |
| 46 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.17206780 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.14904302 |
| 48 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.14136913 |
| 49 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.12929999 |
| 50 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12929823 |
| 51 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.11706857 |
| 52 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10978437 |
| 53 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10475345 |
| 54 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.08279007 |
| 55 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.07089002 |
| 56 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06903443 |
| 57 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.06496782 |
| 58 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.06335671 |
| 59 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.06335671 |
| 60 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.06290304 |
| 61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04561666 |
| 62 | SPI1_23127762_ChIP-Seq_K562_Human | 1.04009653 |
| 63 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02524793 |
| 64 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01540083 |
| 65 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.01428267 |
| 66 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.01114749 |
| 67 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.00794875 |
| 68 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.97680585 |
| 69 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.97104650 |
| 70 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.96893261 |
| 71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.96811271 |
| 72 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.96436928 |
| 73 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.96264910 |
| 74 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.95884076 |
| 75 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.94792521 |
| 76 | * MYC_19829295_ChIP-Seq_ESCs_Human | 0.94610842 |
| 77 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.94480656 |
| 78 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93979058 |
| 79 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93953888 |
| 80 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93751620 |
| 81 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93641555 |
| 82 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.93596625 |
| 83 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.91906940 |
| 84 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.91312300 |
| 85 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.90384209 |
| 86 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90201251 |
| 87 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.89696877 |
| 88 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.87891182 |
| 89 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.87381257 |
| 90 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.87313357 |
| 91 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.87271360 |
| 92 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.87053639 |
| 93 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.86199956 |
| 94 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.86199956 |
| 95 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.85948024 |
| 96 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85685542 |
| 97 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.85254205 |
| 98 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.85082590 |
| 99 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84540814 |
| 100 | CJUN_26792858_Chip-Seq_BT549_Human | 0.84529988 |
| 101 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.84463066 |
| 102 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.84046828 |
| 103 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.83750614 |
| 104 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83567962 |
| 105 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83113689 |
| 106 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.83026639 |
| 107 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.82980229 |
| 108 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.82980229 |
| 109 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82888877 |
| 110 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.82126379 |
| 111 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.81926947 |
| 112 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.81608842 |
| 113 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.80878484 |
| 114 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.80055546 |
| 115 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79417160 |
| 116 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.79262071 |
| 117 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.78932958 |
| 118 | P300_27268052_Chip-Seq_Bcells_Human | 0.78674963 |
| 119 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.78536225 |
| 120 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78364707 |
| 121 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.78075030 |
| 122 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.77893510 |
| 123 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.76847015 |
| 124 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.76734741 |
| 125 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.76408559 |
| 126 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.76042654 |
| 127 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.75811917 |
| 128 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.75811917 |
| 129 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.75719900 |
| 130 | AR_25329375_ChIP-Seq_VCAP_Human | 0.75654508 |
| 131 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.75442799 |
| 132 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.75326370 |
| 133 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.75239777 |
| 134 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.75007038 |
| 135 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.74433291 |
| 136 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.74235189 |
| 137 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.73693278 |
| 138 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.73295885 |
| 139 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72549780 |
| 140 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.72103111 |
| 141 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.70751945 |
| 142 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70258519 |
| 143 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.69812173 |
| 144 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.69336646 |
| 145 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.68341344 |
| 146 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 0.67115685 |
| 147 | * MYB_26560356_Chip-Seq_TH2_Human | 0.67092286 |
| 148 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.66470399 |
| 149 | VDR_22108803_ChIP-Seq_LS180_Human | 0.66403335 |
| 150 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.64910372 |
| 151 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.64889383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006082_CNS_inflammation | 5.56521115 |
| 2 | MP0003724_increased_susceptibility_to | 4.79986764 |
| 3 | MP0003303_peritoneal_inflammation | 4.57430670 |
| 4 | MP0001984_abnormal_olfaction | 3.89077308 |
| 5 | MP0008004_abnormal_stomach_pH | 3.18042349 |
| 6 | MP0005257_abnormal_intraocular_pressure | 3.01552961 |
| 7 | MP0009840_abnormal_foam_cell | 2.92590268 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.91687109 |
| 9 | MP0009278_abnormal_bone_marrow | 2.79688699 |
| 10 | MP0009785_altered_susceptibility_to | 2.73245661 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.73139872 |
| 12 | MP0003436_decreased_susceptibility_to | 2.72914606 |
| 13 | MP0005410_abnormal_fertilization | 2.65358588 |
| 14 | MP0002139_abnormal_hepatobiliary_system | 2.61552729 |
| 15 | MP0005167_abnormal_blood-brain_barrier | 2.61408377 |
| 16 | MP0003195_calcinosis | 2.57341258 |
| 17 | MP0004510_myositis | 2.45559049 |
| 18 | MP0005058_abnormal_lysosome_morphology | 2.39519152 |
| 19 | MP0002277_abnormal_respiratory_mucosa | 2.29941104 |
| 20 | MP0002419_abnormal_innate_immunity | 2.23908671 |
| 21 | MP0002254_reproductive_system_inflammat | 2.19477683 |
| 22 | MP0001533_abnormal_skeleton_physiology | 2.18819276 |
| 23 | MP0005451_abnormal_body_composition | 2.16822985 |
| 24 | MP0001835_abnormal_antigen_presentation | 2.14342124 |
| 25 | MP0005025_abnormal_response_to | 2.00389464 |
| 26 | MP0005164_abnormal_response_to | 1.98323225 |
| 27 | MP0009764_decreased_sensitivity_to | 1.98286419 |
| 28 | MP0002006_tumorigenesis | 1.91805033 |
| 29 | MP0010352_gastrointestinal_tract_polyps | 1.89208997 |
| 30 | MP0003075_altered_response_to | 1.84968595 |
| 31 | MP0004947_skin_inflammation | 1.79092647 |
| 32 | MP0002332_abnormal_exercise_endurance | 1.77867069 |
| 33 | MP0002723_abnormal_immune_serum | 1.76682210 |
| 34 | MP0003690_abnormal_glial_cell | 1.75490655 |
| 35 | MP0002452_abnormal_antigen_presenting | 1.73716545 |
| 36 | MP0003646_muscle_fatigue | 1.60034908 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.59328452 |
| 38 | MP0001790_abnormal_immune_system | 1.59161388 |
| 39 | MP0005387_immune_system_phenotype | 1.59161388 |
| 40 | MP0008469_abnormal_protein_level | 1.57202499 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.55512386 |
| 42 | MP0001800_abnormal_humoral_immune | 1.55232862 |
| 43 | MP0006054_spinal_hemorrhage | 1.54574170 |
| 44 | MP0005166_decreased_susceptibility_to | 1.50737582 |
| 45 | MP0001958_emphysema | 1.50647551 |
| 46 | MP0001853_heart_inflammation | 1.44337092 |
| 47 | MP0001819_abnormal_immune_cell | 1.37337088 |
| 48 | MP0005310_abnormal_salivary_gland | 1.37288368 |
| 49 | MP0002998_abnormal_bone_remodeling | 1.35017866 |
| 50 | MP0003806_abnormal_nucleotide_metabolis | 1.34808938 |
| 51 | MP0002420_abnormal_adaptive_immunity | 1.34383040 |
| 52 | MP0003448_altered_tumor_morphology | 1.32725454 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.31869389 |
| 54 | MP0005464_abnormal_platelet_physiology | 1.29196248 |
| 55 | MP0005360_urolithiasis | 1.28387116 |
| 56 | MP0003183_abnormal_peptide_metabolism | 1.24991542 |
| 57 | MP0000685_abnormal_immune_system | 1.24795765 |
| 58 | MP0000579_abnormal_nail_morphology | 1.22316610 |
| 59 | MP0010155_abnormal_intestine_physiology | 1.20947555 |
| 60 | MP0004858_abnormal_nervous_system | 1.20319918 |
| 61 | MP0010234_abnormal_vibrissa_follicle | 1.16692428 |
| 62 | MP0002736_abnormal_nociception_after | 1.15690994 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 1.15024628 |
| 64 | MP0001545_abnormal_hematopoietic_system | 1.15024628 |
| 65 | MP0005535_abnormal_body_temperature | 1.14834736 |
| 66 | MP0003011_delayed_dark_adaptation | 1.14021369 |
| 67 | MP0003300_gastrointestinal_ulcer | 1.13775983 |
| 68 | MP0005390_skeleton_phenotype | 1.11600873 |
| 69 | MP0003705_abnormal_hypodermis_morpholog | 1.08834821 |
| 70 | MP0003453_abnormal_keratinocyte_physiol | 1.08026710 |
| 71 | MP0002928_abnormal_bile_duct | 1.07427140 |
| 72 | MP0000343_altered_response_to | 1.06805142 |
| 73 | MP0003045_fibrosis | 1.06179527 |
| 74 | MP0009333_abnormal_splenocyte_physiolog | 1.05751075 |
| 75 | MP0000604_amyloidosis | 1.04947187 |
| 76 | MP0005023_abnormal_wound_healing | 1.03475134 |
| 77 | MP0000858_altered_metastatic_potential | 0.99018760 |
| 78 | MP0004859_abnormal_synaptic_plasticity | 0.98721108 |
| 79 | MP0001663_abnormal_digestive_system | 0.97436763 |
| 80 | MP0001501_abnormal_sleep_pattern | 0.96403052 |
| 81 | MP0002877_abnormal_melanocyte_morpholog | 0.96252198 |
| 82 | MP0002653_abnormal_ependyma_morphology | 0.96019119 |
| 83 | MP0009763_increased_sensitivity_to | 0.94214354 |
| 84 | MP0005085_abnormal_gallbladder_physiolo | 0.93250482 |
| 85 | MP0003186_abnormal_redox_activity | 0.92976975 |
| 86 | MP0005671_abnormal_response_to | 0.90110490 |
| 87 | MP0010386_abnormal_urinary_bladder | 0.88519278 |
| 88 | MP0001881_abnormal_mammary_gland | 0.86793532 |
| 89 | MP0003172_abnormal_lysosome_physiology | 0.86146399 |
| 90 | MP0003252_abnormal_bile_duct | 0.84620977 |
| 91 | MP0002405_respiratory_system_inflammati | 0.83030744 |
| 92 | MP0001542_abnormal_bone_strength | 0.82626388 |
| 93 | MP0003950_abnormal_plasma_membrane | 0.82060115 |
| 94 | MP0000920_abnormal_myelination | 0.82048123 |
| 95 | MP0003091_abnormal_cell_migration | 0.81019751 |
| 96 | MP0000716_abnormal_immune_system | 0.80734056 |
| 97 | MP0004742_abnormal_vestibular_system | 0.80692007 |
| 98 | MP0004142_abnormal_muscle_tone | 0.80041756 |
| 99 | MP0002735_abnormal_chemical_nociception | 0.77829467 |
| 100 | MP0002837_dystrophic_cardiac_calcinosis | 0.77264747 |
| 101 | MP0002168_other_aberrant_phenotype | 0.77260444 |
| 102 | MP0005266_abnormal_metabolism | 0.75778788 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.75525959 |
| 104 | MP0005448_abnormal_energy_balance | 0.74098594 |
| 105 | MP0000249_abnormal_blood_vessel | 0.71158038 |
| 106 | MP0002933_joint_inflammation | 0.67910738 |
| 107 | MP0000516_abnormal_urinary_system | 0.66296988 |
| 108 | MP0005367_renal/urinary_system_phenotyp | 0.66296988 |
| 109 | MP0003943_abnormal_hepatobiliary_system | 0.65915964 |
| 110 | MP0005379_endocrine/exocrine_gland_phen | 0.65737435 |
| 111 | MP0002429_abnormal_blood_cell | 0.65480925 |
| 112 | MP0005647_abnormal_sex_gland | 0.65275036 |
| 113 | MP0004043_abnormal_pH_regulation | 0.65037834 |
| 114 | MP0001727_abnormal_embryo_implantation | 0.63212051 |
| 115 | MP0003879_abnormal_hair_cell | 0.63141028 |
| 116 | MP0005595_abnormal_vascular_smooth | 0.62900721 |
| 117 | MP0005083_abnormal_biliary_tract | 0.62041525 |
| 118 | MP0005165_increased_susceptibility_to | 0.60617912 |
| 119 | MP0005381_digestive/alimentary_phenotyp | 0.59840562 |
| 120 | MP0003634_abnormal_glial_cell | 0.59322097 |
| 121 | MP0005187_abnormal_penis_morphology | 0.58857838 |
| 122 | MP0000371_diluted_coat_color | 0.58590867 |
| 123 | MP0002102_abnormal_ear_morphology | 0.58375414 |
| 124 | MP0002136_abnormal_kidney_physiology | 0.57885106 |
| 125 | MP0008873_increased_physiological_sensi | 0.56992386 |
| 126 | MP0009765_abnormal_xenobiotic_induced | 0.56653719 |
| 127 | MP0002398_abnormal_bone_marrow | 0.56424747 |
| 128 | MP0005084_abnormal_gallbladder_morpholo | 0.56401845 |
| 129 | MP0005319_abnormal_enzyme/_coenzyme | 0.56182319 |
| 130 | MP0001764_abnormal_homeostasis | 0.55897531 |
| 131 | MP0000230_abnormal_systemic_arterial | 0.55720034 |
| 132 | MP0008874_decreased_physiological_sensi | 0.55118260 |
| 133 | MP0003795_abnormal_bone_structure | 0.53633962 |
| 134 | MP0001968_abnormal_touch/_nociception | 0.53366455 |
| 135 | MP0004883_abnormal_blood_vessel | 0.52283923 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 5.66196416 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.66196416 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.66196416 |
| 4 | Prostate neoplasm (HP:0100787) | 5.52064909 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.49575465 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.92632669 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 4.84901659 |
| 8 | Optic neuritis (HP:0100653) | 4.84901659 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 4.82626959 |
| 10 | Stomatitis (HP:0010280) | 4.77789093 |
| 11 | Axonal loss (HP:0003447) | 4.57786306 |
| 12 | Basal ganglia calcification (HP:0002135) | 4.55100340 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 4.38352617 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 4.27948052 |
| 15 | Recurrent abscess formation (HP:0002722) | 4.10723071 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.01431620 |
| 17 | Vacuolated lymphocytes (HP:0001922) | 3.96305113 |
| 18 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.84650007 |
| 19 | Myositis (HP:0100614) | 3.77656767 |
| 20 | Nuclear cataract (HP:0100018) | 3.76118890 |
| 21 | Abnormality of macrophages (HP:0004311) | 3.68432921 |
| 22 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.62998487 |
| 23 | Vasculitis (HP:0002633) | 3.62914480 |
| 24 | Porencephaly (HP:0002132) | 3.60108400 |
| 25 | Severe visual impairment (HP:0001141) | 3.57765536 |
| 26 | Keratoconjunctivitis sicca (HP:0001097) | 3.53681879 |
| 27 | Autoimmune thrombocytopenia (HP:0001973) | 3.52947499 |
| 28 | Mutism (HP:0002300) | 3.47720185 |
| 29 | Loss of speech (HP:0002371) | 3.42786267 |
| 30 | Prolonged neonatal jaundice (HP:0006579) | 3.41614430 |
| 31 | Disinhibition (HP:0000734) | 3.40090281 |
| 32 | Keratoconjunctivitis (HP:0001096) | 3.25110360 |
| 33 | Generalized aminoaciduria (HP:0002909) | 3.11031196 |
| 34 | Gangrene (HP:0100758) | 3.10270459 |
| 35 | Urethral obstruction (HP:0000796) | 3.00629488 |
| 36 | Pulmonary artery stenosis (HP:0004415) | 2.98165271 |
| 37 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.89610750 |
| 38 | Interstitial pulmonary disease (HP:0006530) | 2.86801703 |
| 39 | Neurofibrillary tangles (HP:0002185) | 2.76978557 |
| 40 | Fused cervical vertebrae (HP:0002949) | 2.74086460 |
| 41 | Pigmentary retinal degeneration (HP:0001146) | 2.71863804 |
| 42 | Abnormality of the prostate (HP:0008775) | 2.71041453 |
| 43 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.70438336 |
| 44 | Chronic otitis media (HP:0000389) | 2.64911121 |
| 45 | Prolonged bleeding time (HP:0003010) | 2.62230897 |
| 46 | Polyneuropathy (HP:0001271) | 2.61916929 |
| 47 | Chronic bronchitis (HP:0004469) | 2.55218755 |
| 48 | Tetraparesis (HP:0002273) | 2.54435438 |
| 49 | Joint swelling (HP:0001386) | 2.54200126 |
| 50 | Fatigue (HP:0012378) | 2.53862273 |
| 51 | Gastrointestinal stroma tumor (HP:0100723) | 2.53178283 |
| 52 | Bone pain (HP:0002653) | 2.52481713 |
| 53 | Asymmetric septal hypertrophy (HP:0001670) | 2.51863095 |
| 54 | Apathy (HP:0000741) | 2.48515506 |
| 55 | Parakeratosis (HP:0001036) | 2.47986598 |
| 56 | Nausea (HP:0002018) | 2.42945595 |
| 57 | Autoimmune hemolytic anemia (HP:0001890) | 2.42471279 |
| 58 | Amyloidosis (HP:0011034) | 2.40399613 |
| 59 | Pulmonary infiltrates (HP:0002113) | 2.39489241 |
| 60 | Glomerulonephritis (HP:0000099) | 2.39445667 |
| 61 | Short nail (HP:0001799) | 2.38666929 |
| 62 | Diminished motivation (HP:0000745) | 2.38524532 |
| 63 | Peritonitis (HP:0002586) | 2.35755106 |
| 64 | Esophageal neoplasm (HP:0100751) | 2.33935163 |
| 65 | Neoplasm of head and neck (HP:0012288) | 2.33935163 |
| 66 | Increased serum ferritin (HP:0003281) | 2.31767024 |
| 67 | Nephritis (HP:0000123) | 2.30089972 |
| 68 | Gingivitis (HP:0000230) | 2.30064377 |
| 69 | Thick nail (HP:0001805) | 2.28719540 |
| 70 | Leiomyosarcoma (HP:0100243) | 2.27771262 |
| 71 | Uterine leiomyosarcoma (HP:0002891) | 2.27771262 |
| 72 | Abnormality of the pericardium (HP:0001697) | 2.26609399 |
| 73 | Rhinitis (HP:0012384) | 2.26373994 |
| 74 | Pustule (HP:0200039) | 2.25437837 |
| 75 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.24891122 |
| 76 | Metaphyseal irregularity (HP:0003025) | 2.24663309 |
| 77 | Recurrent skin infections (HP:0001581) | 2.21882566 |
| 78 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.19796446 |
| 79 | Purpura (HP:0000979) | 2.19000776 |
| 80 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.18959733 |
| 81 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.18959733 |
| 82 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.18959733 |
| 83 | Hemoptysis (HP:0002105) | 2.17961429 |
| 84 | Abnormality of the periventricular white matter (HP:0002518) | 2.17812485 |
| 85 | Mesangial abnormality (HP:0001966) | 2.16410750 |
| 86 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.15500789 |
| 87 | Absent/shortened dynein arms (HP:0200106) | 2.15500789 |
| 88 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.15350517 |
| 89 | Cleft eyelid (HP:0000625) | 2.15223723 |
| 90 | Premature loss of primary teeth (HP:0006323) | 2.14759214 |
| 91 | Hepatosplenomegaly (HP:0001433) | 2.13774713 |
| 92 | Increased cerebral lipofuscin (HP:0011813) | 2.13606022 |
| 93 | Recurrent viral infections (HP:0004429) | 2.13061479 |
| 94 | Renal Fanconi syndrome (HP:0001994) | 2.12245040 |
| 95 | Episodic fever (HP:0001954) | 2.12079015 |
| 96 | Vertigo (HP:0002321) | 2.11461077 |
| 97 | Nasal polyposis (HP:0100582) | 2.11324721 |
| 98 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.10536805 |
| 99 | Gastrointestinal infarctions (HP:0005244) | 2.09941605 |
| 100 | Orchitis (HP:0100796) | 2.08204868 |
| 101 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 2.07752007 |
| 102 | Acrocyanosis (HP:0001063) | 2.06866335 |
| 103 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.05909084 |
| 104 | Spastic tetraparesis (HP:0001285) | 2.05889830 |
| 105 | Portal hypertension (HP:0001409) | 2.04570797 |
| 106 | Lower limb hyperreflexia (HP:0002395) | 2.04278533 |
| 107 | Inappropriate behavior (HP:0000719) | 2.01791780 |
| 108 | Increased IgM level (HP:0003496) | 2.01687620 |
| 109 | Osteolytic defects of the hand bones (HP:0009699) | 2.01543382 |
| 110 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.01543382 |
| 111 | Recurrent fungal infections (HP:0002841) | 2.01147047 |
| 112 | Dysostosis multiplex (HP:0000943) | 1.99534522 |
| 113 | Abnormality of the nasal mucosa (HP:0000433) | 1.98890839 |
| 114 | Arterial tortuosity (HP:0005116) | 1.97190706 |
| 115 | Vertebral compression fractures (HP:0002953) | 1.96961237 |
| 116 | Agnosia (HP:0010524) | 1.96733989 |
| 117 | Chronic hepatic failure (HP:0100626) | 1.96297174 |
| 118 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.95777872 |
| 119 | Agitation (HP:0000713) | 1.95673737 |
| 120 | Abnormality of Sharpey fibers (HP:0100685) | 1.94830042 |
| 121 | Micronodular cirrhosis (HP:0001413) | 1.94244951 |
| 122 | Mucopolysacchariduria (HP:0008155) | 1.93922575 |
| 123 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.93922575 |
| 124 | Muscle fiber splitting (HP:0003555) | 1.93247091 |
| 125 | Urticaria (HP:0001025) | 1.92788671 |
| 126 | Abnormality of iron homeostasis (HP:0011031) | 1.92280086 |
| 127 | Striae distensae (HP:0001065) | 1.92034060 |
| 128 | Abnormality of macular pigmentation (HP:0008002) | 1.91023514 |
| 129 | Chondrocalcinosis (HP:0000934) | 1.90997383 |
| 130 | Attenuation of retinal blood vessels (HP:0007843) | 1.90329504 |
| 131 | Arterial thrombosis (HP:0004420) | 1.90022746 |
| 132 | Male infertility (HP:0003251) | 1.89520410 |
| 133 | Increased IgE level (HP:0003212) | 1.88726487 |
| 134 | Petechiae (HP:0000967) | 1.88523118 |
| 135 | Hypergammaglobulinemia (HP:0010702) | 1.88502810 |
| 136 | Irregular vertebral endplates (HP:0003301) | 1.88423219 |
| 137 | Palpebral edema (HP:0100540) | 1.88414982 |
| 138 | Personality changes (HP:0000751) | 1.87384260 |
| 139 | Chronic obstructive pulmonary disease (HP:0006510) | 1.87367558 |
| 140 | Obstructive lung disease (HP:0006536) | 1.87367558 |
| 141 | Anorexia (HP:0002039) | 1.86752277 |
| 142 | Arthralgia (HP:0002829) | 1.86026838 |
| 143 | Keratitis (HP:0000491) | 1.85847471 |
| 144 | Abnormality of the costochondral junction (HP:0000919) | 1.84142978 |
| 145 | Abnormality of the hepatic vasculature (HP:0006707) | 1.83788616 |
| 146 | Hemorrhage of the eye (HP:0011885) | 1.83749528 |
| 147 | Abnormality of B cell number (HP:0010975) | 1.83166620 |
| 148 | Prolonged QT interval (HP:0001657) | 1.83149475 |
| 149 | Aplasia cutis congenita (HP:0001057) | 1.82838166 |
| 150 | Polydipsia (HP:0001959) | 1.82659135 |
| 151 | Abnormal drinking behavior (HP:0030082) | 1.82659135 |
| 152 | Poor head control (HP:0002421) | 1.82040890 |
| 153 | Exocrine pancreatic insufficiency (HP:0001738) | 1.81514459 |
| 154 | Opisthotonus (HP:0002179) | 1.80037590 |
| 155 | Emphysema (HP:0002097) | 1.78252029 |
| 156 | Amaurosis fugax (HP:0100576) | 1.77908658 |
| 157 | Recurrent pneumonia (HP:0006532) | 1.77684094 |
| 158 | Malnutrition (HP:0004395) | 1.77065017 |
| 159 | Progressive neurologic deterioration (HP:0002344) | 1.76767179 |
| 160 | Erythroderma (HP:0001019) | 1.75506852 |
| 161 | Absent frontal sinuses (HP:0002688) | 1.75460669 |
| 162 | Abnormality of purine metabolism (HP:0004352) | 1.74913326 |
| 163 | Periodontitis (HP:0000704) | 1.74773891 |
| 164 | Hyperextensible skin (HP:0000974) | 1.74646784 |
| 165 | Abnormality of the pleura (HP:0002103) | 1.74061238 |
| 166 | Plantar hyperkeratosis (HP:0007556) | 1.72592513 |
| 167 | Enlarged epiphyses (HP:0010580) | 1.71983744 |
| 168 | Palmoplantar hyperkeratosis (HP:0000972) | 1.71607201 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 5.55348538 |
| 2 | ARAF | 4.50023234 |
| 3 | IRAK4 | 3.83741416 |
| 4 | CASK | 3.34686753 |
| 5 | MAP3K13 | 3.31159686 |
| 6 | MAP3K14 | 3.26453651 |
| 7 | RIPK4 | 3.07411018 |
| 8 | PIM2 | 2.85933750 |
| 9 | IRAK3 | 2.80337127 |
| 10 | MAP3K9 | 2.79600118 |
| 11 | TAOK2 | 2.75809853 |
| 12 | NME2 | 2.71821411 |
| 13 | TXK | 2.41642826 |
| 14 | TAOK1 | 2.35813803 |
| 15 | KSR2 | 2.33582977 |
| 16 | TYK2 | 2.13571810 |
| 17 | PLK4 | 2.08634978 |
| 18 | MAP3K11 | 2.05921363 |
| 19 | TBK1 | 2.03841629 |
| 20 | BRAF | 1.87717973 |
| 21 | CSK | 1.80905699 |
| 22 | STK38L | 1.79885876 |
| 23 | KIT | 1.74549021 |
| 24 | IRAK1 | 1.71711391 |
| 25 | IRAK2 | 1.66159398 |
| 26 | JAK1 | 1.64433916 |
| 27 | MAP3K2 | 1.64306321 |
| 28 | MAP3K12 | 1.51253065 |
| 29 | TGFBR2 | 1.47439608 |
| 30 | IKBKE | 1.46244779 |
| 31 | PKN1 | 1.45190475 |
| 32 | MAP3K5 | 1.43859049 |
| 33 | BLK | 1.42155470 |
| 34 | RIPK1 | 1.38770167 |
| 35 | FGR | 1.37293479 |
| 36 | TRIM28 | 1.35263005 |
| 37 | STK24 | 1.32217232 |
| 38 | MAP4K2 | 1.31747661 |
| 39 | ACVR1B | 1.30057838 |
| 40 | ERBB4 | 1.29622192 |
| 41 | GRK7 | 1.19919587 |
| 42 | ERBB3 | 1.19319146 |
| 43 | CDC42BPA | 1.17248870 |
| 44 | MATK | 1.06754839 |
| 45 | RAF1 | 1.05879975 |
| 46 | PIM1 | 1.03592418 |
| 47 | FRK | 0.99252345 |
| 48 | TYRO3 | 0.95917575 |
| 49 | NUAK1 | 0.94884341 |
| 50 | CCNB1 | 0.90496209 |
| 51 | MOS | 0.89540027 |
| 52 | BCKDK | 0.86947468 |
| 53 | LYN | 0.82849482 |
| 54 | PDK2 | 0.80500767 |
| 55 | HCK | 0.78974069 |
| 56 | EIF2AK2 | 0.76117093 |
| 57 | PLK2 | 0.76100468 |
| 58 | CAMKK2 | 0.75715826 |
| 59 | JAK3 | 0.75124373 |
| 60 | BMX | 0.74849085 |
| 61 | DYRK3 | 0.74637914 |
| 62 | STK10 | 0.73738075 |
| 63 | PIK3CG | 0.72857838 |
| 64 | FYN | 0.72532848 |
| 65 | JAK2 | 0.68679252 |
| 66 | MARK3 | 0.68358747 |
| 67 | STK3 | 0.65078993 |
| 68 | ADRBK2 | 0.64961372 |
| 69 | MAP3K3 | 0.64443101 |
| 70 | LATS1 | 0.63654131 |
| 71 | SIK2 | 0.62226233 |
| 72 | STK4 | 0.61941528 |
| 73 | BRD4 | 0.61885121 |
| 74 | IKBKB | 0.61540804 |
| 75 | DAPK3 | 0.60148743 |
| 76 | MAP2K6 | 0.59052647 |
| 77 | PRKD2 | 0.58190028 |
| 78 | ERN1 | 0.57209395 |
| 79 | RPS6KA4 | 0.56993364 |
| 80 | BMPR2 | 0.56396702 |
| 81 | GRK1 | 0.55953466 |
| 82 | CAMK1G | 0.55425781 |
| 83 | SYK | 0.55369692 |
| 84 | NTRK3 | 0.54791755 |
| 85 | ALK | 0.54764343 |
| 86 | CSNK1A1L | 0.53303166 |
| 87 | LATS2 | 0.50159358 |
| 88 | TRPM7 | 0.49723214 |
| 89 | MELK | 0.49374257 |
| 90 | DAPK2 | 0.48836399 |
| 91 | TESK1 | 0.46624916 |
| 92 | FES | 0.44432184 |
| 93 | LMTK2 | 0.43643537 |
| 94 | STK16 | 0.42641611 |
| 95 | MAP4K1 | 0.42211373 |
| 96 | CDK6 | 0.41297654 |
| 97 | NEK9 | 0.41258572 |
| 98 | PRKG2 | 0.41138991 |
| 99 | MUSK | 0.40811942 |
| 100 | PDK1 | 0.40000490 |
| 101 | INSRR | 0.39944842 |
| 102 | PAK3 | 0.39875113 |
| 103 | CAMK1D | 0.38836895 |
| 104 | MAP2K2 | 0.38608977 |
| 105 | MAP3K1 | 0.38535335 |
| 106 | PDPK1 | 0.38239769 |
| 107 | STK11 | 0.37938143 |
| 108 | LCK | 0.37587923 |
| 109 | PRKCQ | 0.37279859 |
| 110 | CSNK1G3 | 0.36861542 |
| 111 | EGFR | 0.36808113 |
| 112 | CSF1R | 0.36554383 |
| 113 | SIK3 | 0.36492516 |
| 114 | ABL2 | 0.36002293 |
| 115 | PRKCH | 0.34532456 |
| 116 | SGK1 | 0.34524062 |
| 117 | PKN2 | 0.34446202 |
| 118 | CSNK1G1 | 0.33852224 |
| 119 | MAPK4 | 0.33065934 |
| 120 | MAPK11 | 0.32044068 |
| 121 | TLK1 | 0.32025425 |
| 122 | CDK4 | 0.32007441 |
| 123 | DYRK1B | 0.31610138 |
| 124 | WNK1 | 0.30361523 |
| 125 | CHUK | 0.29782309 |
| 126 | DDR2 | 0.28769056 |
| 127 | PRKAA2 | 0.28005414 |
| 128 | PTK2B | 0.27895927 |
| 129 | CAMK2G | 0.27626819 |
| 130 | ABL1 | 0.26695400 |
| 131 | NLK | 0.26575874 |
| 132 | MAP2K1 | 0.26100709 |
| 133 | TAOK3 | 0.25789385 |
| 134 | ZAP70 | 0.25578461 |
| 135 | CLK1 | 0.25240036 |
| 136 | INSR | 0.24647138 |
| 137 | TNIK | 0.24576351 |
| 138 | STK38 | 0.23719767 |
| 139 | WNK3 | 0.21158378 |
| 140 | TESK2 | 0.19852999 |
| 141 | HIPK2 | 0.17511332 |
| 142 | BTK | 0.17262491 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.28495453 |
| 2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.33992939 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.28639874 |
| 4 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.20267748 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 3.07585509 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.90889066 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.69830975 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.41123709 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 2.39714133 |
| 10 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.35550422 |
| 11 | Legionellosis_Homo sapiens_hsa05134 | 2.26288710 |
| 12 | Prion diseases_Homo sapiens_hsa05020 | 2.24265678 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.21145666 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.20211122 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.19692837 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.17634647 |
| 17 | Salmonella infection_Homo sapiens_hsa05132 | 2.13084002 |
| 18 | Influenza A_Homo sapiens_hsa05164 | 2.10949254 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.09511989 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.08044920 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.94074781 |
| 22 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.89140158 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.85851036 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.79088558 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.75973011 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.63760155 |
| 27 | Allograft rejection_Homo sapiens_hsa05330 | 1.53547982 |
| 28 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.49404609 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.38748008 |
| 30 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.36391324 |
| 31 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.33018812 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.30980966 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.28859138 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.25677455 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.22715251 |
| 36 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.18039115 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.15730779 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.10748639 |
| 39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.09210564 |
| 40 | Amoebiasis_Homo sapiens_hsa05146 | 1.09142232 |
| 41 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.04391045 |
| 42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.03169497 |
| 43 | Hepatitis C_Homo sapiens_hsa05160 | 1.01889523 |
| 44 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.01607831 |
| 45 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.00862860 |
| 46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.00700606 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.99743689 |
| 48 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.98660349 |
| 49 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.96086117 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 0.94973831 |
| 51 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92907161 |
| 52 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.92325396 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 0.83989980 |
| 54 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.76801498 |
| 55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.75766218 |
| 56 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.72210893 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 0.72188133 |
| 58 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.70288350 |
| 59 | Mineral absorption_Homo sapiens_hsa04978 | 0.70134487 |
| 60 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.68888531 |
| 61 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.68881170 |
| 62 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.67073772 |
| 63 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65990373 |
| 64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65976058 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65044632 |
| 66 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.62119674 |
| 67 | Bladder cancer_Homo sapiens_hsa05219 | 0.57767463 |
| 68 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.56934771 |
| 69 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53957893 |
| 70 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.50522821 |
| 71 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50058343 |
| 72 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48232787 |
| 73 | Apoptosis_Homo sapiens_hsa04210 | 0.48163312 |
| 74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47906333 |
| 75 | Lysosome_Homo sapiens_hsa04142 | 0.46782298 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45723870 |
| 77 | Shigellosis_Homo sapiens_hsa05131 | 0.44603653 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43598789 |
| 79 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.43584790 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.41924745 |
| 81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41666389 |
| 82 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.39875873 |
| 83 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.39564265 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39207717 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39109262 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.38840946 |
| 87 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.38088272 |
| 88 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.37981932 |
| 89 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.37746226 |
| 90 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.36984183 |
| 91 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.36695255 |
| 92 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.35457831 |
| 93 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.35007618 |
| 94 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34172265 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.33424529 |
| 96 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.31846799 |
| 97 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.29345199 |
| 98 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.29235900 |
| 99 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.29198591 |
| 100 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.28519188 |
| 101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.28498657 |
| 102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28441715 |
| 103 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.28367467 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27303717 |
| 105 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.26730730 |
| 106 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.25675170 |
| 107 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.25077348 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.24733593 |
| 109 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.23825734 |
| 110 | ABC transporters_Homo sapiens_hsa02010 | 0.21602426 |
| 111 | Salivary secretion_Homo sapiens_hsa04970 | 0.21458297 |
| 112 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.21356428 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.21329270 |
| 114 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.21021867 |
| 115 | Morphine addiction_Homo sapiens_hsa05032 | 0.20193997 |
| 116 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.19914849 |
| 117 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.19570603 |
| 118 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.19214953 |
| 119 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.19035500 |
| 120 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.18253584 |
| 121 | Melanogenesis_Homo sapiens_hsa04916 | 0.17843275 |
| 122 | Long-term depression_Homo sapiens_hsa04730 | 0.17769767 |
| 123 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.17009121 |
| 124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.16982429 |
| 125 | Phototransduction_Homo sapiens_hsa04744 | 0.16763173 |
| 126 | Viral myocarditis_Homo sapiens_hsa05416 | 0.16594445 |
| 127 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.16305373 |
| 128 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.16254502 |
| 129 | Histidine metabolism_Homo sapiens_hsa00340 | 0.14804060 |
| 130 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.14725189 |
| 131 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.14558679 |
| 132 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.14542427 |
| 133 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.14516706 |

